Sarcoma: Concordance Between Initial Diagnosis and Centralized Expert Review in a Population-based Study Within Three European Regions

Overview

Journal Ann Oncol

Publisher Elsevier

Specialty Oncology

Date 2012 Feb 15

PMID 22331640

Citations 84

Authors

I Ray-Coquard

M C Montesco

J M Coindre

A P Dei Tos

A Lurkin

D Ranchere-Vince

A Vecchiato

A V Decouvelaere

S Mathoulin-Pelissier

S Albert

P Cousin

D Cellier

L Toffolatti

C R Rossi

J Y Blay

Affiliations

Soon will be listed here.

Abstract

Background: Sarcomas represent a heterogeneous group of tumors. Accurate determination of histological diagnosis and prognostic factors is critical for the delineation of treatment strategies. The contribution of second opinion (SO) to improve diagnostic accuracy has been suggested for sarcoma but has never been established in population-based studies.

Methods: Histological data of patients diagnosed with sarcoma in Rhone-Alpes (France), Veneto (Italy) and Aquitaine (France) over a 2-year period were collected. Initial diagnoses were systematically compared with SO from regional and national experts.

Results: Of 2016 selected patients, 1463 (73%) matched the inclusion criteria and were analyzed. Full concordance between primary diagnosis and SO (the first pathologist and the expert reached identical conclusions) was observed in 824 (56%) cases, partial concordance (identical diagnosis of connective tumor but different grade or histological subtype) in 518 (35%) cases and complete discordance (benign versus malignant, different histological type or invalidation of the diagnosis of sarcoma) in 121 (8%) cases. The major discrepancies were related to histological grade (n = 274, 43%), histological type (n = 144, 24%), subtype (n = 18, 3%) and grade plus subtype or grade plus histological type (n = 178, 29%).

Conclusion: More than 40% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions.

Citing Articles

Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors.

Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, Studer G, Fuchs B Cancers (Basel). 2025; 17(3).

PMID: 39941878 PMC: 11816265. DOI: 10.3390/cancers17030510.

Lymphadenectomy in the treatment of sarcomas - indications and technique.

Dunaj P, Zukowska E, Czarnecka A, Krotewicz M, Borkowska A, Chmiel P Oncol Rev. 2024; 18:1413734.

PMID: 39737200 PMC: 11683405. DOI: 10.3389/or.2024.1413734.

Intracranial pleomorphic liposarcoma misclassified as a pleomorphic xanthoastrocytoma by a DNA methylation classifier: illustrative case.

Go K, Makino Y, Takeuchi Y, Minamiguchi S, Takada S, Sano N J Neurosurg Case Lessons. 2024; 8(19).

PMID: 39496157 PMC: 11539281. DOI: 10.3171/CASE24465.

Primary Retrovesical Leiomyosarcoma: A Case Report.

Rudy R, LeRoy D, Goldberg J Cureus. 2024; 16(9):e69422.

PMID: 39411630 PMC: 11473208. DOI: 10.7759/cureus.69422.

Biphenotypic sinonasal sarcoma diagnosed by detection of fusion gene using integrated whole-genome and transcriptome sequencing.

Okada S, Serizawa M, Sato F, Goto S, Nagashima T, Ohshima K Int Cancer Conf J. 2024; 13(4):412-421.

PMID: 39398935 PMC: 11464723. DOI: 10.1007/s13691-024-00703-4.

References

Bridge J, Sandberg A . Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000; 29(5):249-58. DOI: 10.1007/s002560050603. View

Singer S, Corson J, Demetri G, Healey E, Marcus K, Eberlein T . Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995; 221(2):185-95. PMC: 1234952. DOI: 10.1097/00000658-199502000-00009. View

Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K . Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol. 2002; 33(1):111-5. DOI: 10.1053/hupa.2002.30184. View

Coindre J, Trojani M, Contesso G, David M, Rouesse J, Bui N . Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986; 58(2):306-9. DOI: 10.1002/1097-0142(19860715)58:2<306::aid-cncr2820580216>3.0.co;2-7. View

LaCasce A, Kho M, Friedberg J, Niland J, Abel G, Rodriguez M . Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008; 26(31):5107-12. PMC: 2652094. DOI: 10.1200/JCO.2008.16.4061. View

Ducimetiere F, Lurkin A, Ranchere-Vince D, Decouvelaere A, Isaac S, Claret-Tournier C . [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region]. Bull Cancer. 2010; 97(6):629-41. DOI: 10.1684/bdc.2010.1117. View

Lurkin A, Ducimetiere F, Ranchere Vince D, Decouvelaere A, Cellier D, Gilly F . Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region. BMC Cancer. 2010; 10:150. PMC: 2873387. DOI: 10.1186/1471-2407-10-150. View

Guillou L, Coindre J, Bonichon F, Nguyen B, Terrier P, Collin F . Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997; 15(1):350-62. DOI: 10.1200/JCO.1997.15.1.350. View

Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin J, Sunyach M . Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004; 15(2):307-15. DOI: 10.1093/annonc/mdh058. View

10.

Casali P, Jost L, Sleijfer S, Verweij J, Blay J . Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008; 19 Suppl 2:ii89-93. DOI: 10.1093/annonc/mdn101. View

11.

Meis-Kindblom J, Bjerkehage B, Bohling T, Domanski H, Halvorsen T, Larsson O . Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl. 1999; 285:18-26. DOI: 10.1080/17453674.1999.11744818. View

12.

Arbiser Z, Folpe A, Weiss S . Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001; 116(4):473-6. DOI: 10.1309/425H-NW4W-XC9A-005H. View

13.

Harris M, Hartley A, Blair V, Birch J, Banerjee S, Freemont A . Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991; 64(2):315-20. PMC: 1977501. DOI: 10.1038/bjc.1991.298. View

14.

Hassoun J, Bataillard A, Voigt J, Coindre J, Anger E, Bellocq J . [Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]. Bull Cancer. 2005; 91(12):941-57. View

15.

Ray-Coquard I, Chauvin F, Lurkin A, Ducimetiere F, Jacquin J, Agostini C . Medical practices and cancer care networks: examples in oncology. Bull Cancer. 2006; 93(2):E13-20. View

16.

Sandberg A, Bridge J . Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet. 2000; 123(1):1-26. DOI: 10.1016/s0165-4608(00)00295-8. View

17.

Mastrangelo G, Fadda E, Cegolon L, Montesco M, Ray-Coquard I, Buja A . A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health. 2010; 10:188. PMC: 2882909. DOI: 10.1186/1471-2458-10-188. View

18.

Lind A, Bewtra C, Healy J, Sims K . Prospective peer review in surgical pathology. Am J Clin Pathol. 1995; 104(5):560-6. DOI: 10.1093/ajcp/104.5.560. View

19.

Pisters P, Leung D, Woodruff J, Shi W, Brennan M . Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996; 14(5):1679-89. DOI: 10.1200/JCO.1996.14.5.1679. View

20.

Coindre J, Nguyen B, Goussot J, de Mascarel I, Maree D, de Mascarel A . [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol. 1985; 5(2):95-9. View